CEO of Cell Therapeutics Inc. (CTIC, Financial) James A Bianco sells 250,000 shares of CTIC on 08/10/2010 at an average price of $0.4 a share.
Cell Therapeutics Inc. has a market cap of $256.5 million; its shares were traded at around $0.3894 with and P/S ratio of 3206.3.
Cell Therapeutics Inc. has a market cap of $256.5 million; its shares were traded at around $0.3894 with and P/S ratio of 3206.3.
CEO Recent Trades:
- Sell: CEO James A Bianco sold 500,000 shares of CTIC stock on 06/30/2010 at the average price of 0.37. James A Bianco owns at least 3,706,050 shares after this. The price of the stock has increased by 5.24% since.
Directors and Officers Recent Trades:
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 07/30/2010 at the average price of 0.4. Phillip M Phd Nudelman owns at least 2,494,865 shares after this. The price of the stock has decreased by 2.65% since.
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 06/30/2010 at the average price of 0.39. Phillip M Phd Nudelman owns at least 1,036,306 shares after this. The price of the stock has decreased by 0.15% since.
- Sell: Director Fred Telling sold 105,823 shares of CTIC stock on 06/29/2010 at the average price of 0.42. Fred Telling owns at least 787,262 shares after this. The price of the stock has decreased by 7.29% since.
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 05/28/2010 at the average price of 0.39. Phillip M Phd Nudelman owns at least 1,076,306 shares after this. The price of the stock has decreased by 0.15% since.
- Sell: Director Richard L Love sold 11,300 shares of CTIC stock on 05/24/2010 at the average price of 0.38. Richard L Love owns at least 1,436,112 shares after this. The price of the stock has increased by 2.47% since.
